Page last updated: 2024-12-06

tobanum

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tobanum: tobanum is for (+-)-isomer, HCl salt; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65814
CHEMBL ID156791
CHEBI ID135217
SCHEMBL ID80493
MeSH IDM0085448

Synonyms (29)

Synonym
tobanum
cloranolol (inn)
D07183
39563-28-5
1-(tert-butylamino)-3-(2,5-dichlorophenoxy)-2-propanol
cloranolol
chloranolol
2-propanol, 1-(2,5-dichlorophenoxy)-3-((1,1-dimethylethyl)amino)-
cloranolol [inn]
cloranololum [inn-latin]
L013381
CHEBI:135217
CHEMBL156791
1-(tert-butylamino)-3-(2,5-dichlorophenoxy)propan-2-ol
FT-0664521
cloranololum
gyki 41099
q3u058h86v ,
unii-q3u058h86v
(rs)-1-tert-butylamino-3-(2,5-dichlorphenoxy)-2-propanol
AKOS008962466
SCHEMBL80493
cloranolol [mi]
cloranolol [who-dd]
Z55682028
Q4859862
DB13508
DTXSID30865962
EN300-7512496

Research Excerpts

Overview

Tobanum seems to be a very effective antiarrhythmic drug for the treatment of supraventricular tachycardias.

ExcerptReferenceRelevance
"Tobanum seems to be a very effective antiarrhythmic drug for the treatment of supraventricular tachycardias."( Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
Czakó, E; Solti, F, 1980
)
1.25
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199028 (93.33)18.7374
1990's2 (6.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials11 (36.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (63.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]